Which NSCLC patients should receive chemotherapy and anti-angiogenics?

Anti-angiogenic therapy has proven to be useful tool for the treatment of non-small cell lung cancer (NSCLC) in the frontline setting. Excitingly, there are now anti-angiogenic agents that can be used... Author: VJOncology Added: 04/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts